The LEAD Coalition has submitted its FY2027 appropriations letter to Congress. The letter, signed by 475 LEAD Coalition member organizations and allies, urges Congress to reassert our country’s non-partisan national priority to overcome Alzheimer’s disease and related disorders (AD/ADRD) by making robust appropriations for federal agencies and ensuring complete and timely expenditure of those funds […]

On March 9, the LEAD Coalition (Leaders Engaged on Alzheimer’s Disease), the Alzheimer’s Association, and the Alzheimer’s Impact Movement (AIM) – along with 451 signatories – wrote to Congress in support of the bipartisan Alzheimer’s Screening and Prevention (ASAP) Act (H.R. 6130 / S.3267). The ASAP Act would authorize the Secretary of Health and Human Services to allow […]

Read the February 25th LEAD Coalition Newsletter below.

Read the January 28th LEAD Coalition Newsletter below.

Read the December 30th LEAD Coalition Newsletter below.

Read the November 24th LEAD Coalition Newsletter below.

Read the October 29th LEAD Coalition Newsletter below.

Read the September 30th LEAD Coalition Newsletter below.

On September 9, 400 LEAD Coalition member organizations and allies wrote to Congress in support of S. 1799 / H.R. 3501, informally called The Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act. The CHANGE Act will strengthen dementia detection and, in turn, catalyze improved care, promote health equity, and accelerate science to prevent, […]

Read the August 27th LEAD Coalition Newsletter below.